Literature DB >> 284401

Desensitization of the insulin receptor at an early postreceptor step by prolonged exposure to antireceptor antibody.

F A Karlsson, E Van Obberghen, C Grunfeld, C R Kahn.   

Abstract

We have used an adipocyte-like cell line, the 3T3-L1 fatty fibroblasts, to compare acute and chronic effects of autoantibodies directed against the insulin receptor. Acute exposure of the cells in tissue culture to the antibodies resulted in a blockade of insulin binding and stimulation of 2-deoxy-glucose transport and glucose oxidation. Maximal acute effects were reached within 30-120 min. Subsequently, the stimulatory response decayed and, after 6 hr in the continuous presence of the antibodies, basal glucose metabolism had returned to the level observed with unexposed cells and a state of severe insulin resistance prevailed. In contrast to the decay of bioresponse, no change in insulin binding was detectable over the same time period. The mechanism of desensitization seemed to involve events early after insulin binding to receptor because cells exposed to antibody for prolonged periods of time, although unresponsive to insulin and antireceptor antibodies, responded normally to both spermine and vitamin K(5), agents that stimulate glucose metabolism independently of the insulin receptor. These data suggest that prolonged or continuous occupancy of the insulin receptor by a ligand, in this case antireceptor antibodies, does not produce a continuous biological response. Instead, there is desensitization at some early step in the pathway for insulin action. These observations have important implications with respect to the mechanism of insulin action and to other situations in which there is long-term exposure of cells to antibodies that react with membrane components.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 284401      PMCID: PMC383058          DOI: 10.1073/pnas.76.2.809

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Autoantibodies to the insulin receptor. Effect on the insulin-receptor interaction in IM-9 lymphocytes.

Authors:  J S Flier; C R Kahn; D B Jarrett; J Roth
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

2.  Acquisition of increased hormone sensitivity during in vitro adipocyte development.

Authors:  C S Rubin; E Lai; O M Rosen
Journal:  J Biol Chem       Date:  1977-05-25       Impact factor: 5.157

3.  Effects of autoantibodies to the insulin receptor on isolated adipocytes. Studies of insulin binding and insulin action.

Authors:  C R Kahn; K Baird; J S Filier; D B Jarrett
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

4.  Direct demonstration that receptor crosslinking or aggregation is important in insulin action.

Authors:  C R Kahn; K L Baird; D B Jarrett; J S Flier
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

Review 5.  The insulin receptor: its role in insulin resistance of obesity and diabetes.

Authors:  J M Olefsky
Journal:  Diabetes       Date:  1976-12       Impact factor: 9.461

6.  Effects of antiinsulin receptor autoantibody on the metabolism of rat adipocytes.

Authors:  M Kasuga; Y Akanuma; T Tsushima; K Suzuki; K Kosaka; M Kibata
Journal:  J Clin Endocrinol Metab       Date:  1978-07       Impact factor: 5.958

7.  Anti-insulin receptor antibodies inhibit insulin binding and stimulate glucose metabolism in skeletal muscle.

Authors:  Y Le Marchand-Brustel; P Gorden; J S Flier; C R Kahn; P Freychet
Journal:  Diabetologia       Date:  1978-05       Impact factor: 10.122

8.  Insulin-dependent regulation of the insulin-sensitivity of adipocytes.

Authors:  J N Livingston; B J Purvis; D H Lockwood
Journal:  Nature       Date:  1978-06-01       Impact factor: 49.962

9.  Characterization of antibodies to the insulin receptor: a cause of insulin-resistant diabetes in man.

Authors:  J S Flier; C R Kahn; D B Jarrett; J Roth
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

10.  Receptors for peptide hormones. New insights into the pathophysiology of disease states in man.

Authors:  C R Kahn; K Megyesi; R S Bar; R C Eastman; J S Flier
Journal:  Ann Intern Med       Date:  1977-02       Impact factor: 25.391

View more
  14 in total

Review 1.  Antibodies directed to the insulin receptor. Clinical aspects and applications to the study of insulin action.

Authors:  R De Pirro; P Borboni; M A Marini; A Montemurro; G Sesti; R Lauro
Journal:  J Endocrinol Invest       Date:  1990-12       Impact factor: 4.256

Review 2.  Specificities of autoantibodies in autoimmune receptor diseases.

Authors:  M H De Baets
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

3.  Long-term regulation of hexose transport by insulin in cultured mouse (3T3) adipocytes.

Authors:  J P van Putten; T Wieringa; H M Krans
Journal:  Diabetologia       Date:  1985-01       Impact factor: 10.122

4.  Adipose cell differentiation in culture.

Authors:  G Ailhaud
Journal:  Mol Cell Biochem       Date:  1982-11-12       Impact factor: 3.396

5.  Prolactin-like activity of anti-prolactin receptor antibodies on casein and DNA synthesis in the mammary gland.

Authors:  J Djiane; L M Houdebine; P A Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

6.  Antibody-induced desensitization of the insulin receptor. Studies of the mechanism of desensitization in 3T3-L1 fatty fibroblasts.

Authors:  C Grunfeld; E Van Obberghen; F A Karlsson; C R Kahn
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

7.  Antibody against the insulin receptor causes disappearance of insulin receptors in 3T3-L1 cells: a possible explanation of antibody-induced insulin resistance.

Authors:  C Grunfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

8.  A study of the adipose conversion of suspended 3T3 cells by using glycerophosphate dehydrogenase as differentiation marker.

Authors:  J Pairault; H Green
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

9.  In vitro studies on the mechanism of action of a new antiallergic, Ro 21-7634.

Authors:  A F Welton; W C Hope; H J Crowley; R A Salvador
Journal:  Agents Actions       Date:  1981-07

10.  Xenogeneic antiserum to soluble products from activated lymphoid cells inhibits interleukin 1-mediated functions in the helper pathway of cytolytic-effector-cell differentiation.

Authors:  J D McMannis; J M Plate
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.